CN105694120B - A kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle - Google Patents

A kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle Download PDF

Info

Publication number
CN105694120B
CN105694120B CN201410699380.2A CN201410699380A CN105694120B CN 105694120 B CN105694120 B CN 105694120B CN 201410699380 A CN201410699380 A CN 201410699380A CN 105694120 B CN105694120 B CN 105694120B
Authority
CN
China
Prior art keywords
hyaluronic acid
chitosan oligosaccharide
solution
nano particle
composite nano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410699380.2A
Other languages
Chinese (zh)
Other versions
CN105694120A (en
Inventor
刘雅
陈西广
程晓杰
孔明
冯超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ocean University of China
Original Assignee
Ocean University of China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocean University of China filed Critical Ocean University of China
Priority to CN201410699380.2A priority Critical patent/CN105694120B/en
Publication of CN105694120A publication Critical patent/CN105694120A/en
Application granted granted Critical
Publication of CN105694120B publication Critical patent/CN105694120B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a kind of technology of preparing of the nanoparticle in high molecular material field, i.e., a kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle, the present invention, as raw material, synthesizes target product by polymer agglomerates method using chitosan oligosaccharide and hyaluronic acid.Specific steps are as follows: be dissolved in chitosan oligosaccharide, hyaluronic acid in deionized water respectively, obtain chitosan oligosaccharide solution and hyaluronic acid solution, one of above two solution is slowly dropped under agitation in another solution, carry out polymer precipitation reaction, when dripping quantity is close to half, stop being added dropwise, then resulting reaction system is reversely added drop-wise in former solution, and is kept stirring.The mass ratio of speed of agitator, the concentration of chitosan oligosaccharide, the concentration of hyaluronic acid, chitosan oligosaccharide and hyaluronic acid and the rate of addition of solution are controlled, to end of reaction, ultrasonic disperse is isolated and purified, and is dried to obtain product of the invention.The average grain diameter of product is -20mV-+30mV in 120-200nm, Zeta potential, can be used as pharmaceutical carrier and biomaterial for medical purpose, has good research and development prospect.

Description

A kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle
Technical field
The invention belongs to a kind of preparation methods of chitosan oligosaccharide hyaluronic acid composite nano particle of technical field of biological material.
Background technique
Chitosan oligosaccharide is called Chitosan poly oligosaccharide, chitosan oligomer, is using chitosan as raw material, one made of degrading through biotechnology Kind oligosaccharide product.Good water solubility, the bioactivity of chitosan oligosaccharide are high, and in human body internal absorption factor nearly 100%, effect is chitosan Decades of times, the effect to human body includes immunological regulation, antitumor, reducing blood lipid, adjust blood glucose, improve liver and cardio-pulmonary function and its His different physiological roles.In existing research invention, once had been reported that and chitosan oligosaccharide nanoparticle is prepared for by solvent diffusion method, and The case where human lung adenocarcinoma cell absorbs it has been investigated, has disclosed chitosan oligosaccharide nanoparticle as biopharmaceutical macromolecular drug carrier Potential function.It also has been reported that and glycosyl galactose chitosan oligosaccharide nanoparticle is prepared for by microemulsified-gelling process, be with diammonium glycyrrhizinate Model drug has investigated its liver target function.However, the nanoparticle stability of above method preparation is poor, preparation process phase It is not easy to remove to complexity, using emulsifier and dispersing agent etc., reduces its biocompatibility, affect it and be used as drug in vivo The application of carrier.Therefore, the present invention is directed to prepare a kind of stability is strong, good dispersion, preparation process are simple, mild condition and Nanoparticle with certain targeting is of great significance for drug encapsulation, release and the targeted delivery under physiological condition.
Summary of the invention
It is existing to make up the object of the present invention is to provide a kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle The shortcomings that technique.
The present invention, as raw material, synthesizes chitosan oligosaccharide hyaluronic acid by polymer agglomerates method using chitosan oligosaccharide and hyaluronic acid Composite nano particle.Specific steps are as follows: chitosan oligosaccharide, hyaluronic acid are dissolved in deionized water respectively, obtain chitosan oligosaccharide solution and One of above two solution is slowly dropped in another solution under agitation, is gathered by hyaluronic acid solution Object precipitation reaction is closed, when dripping quantity is close to half, stops being added dropwise, resulting reaction system is reversely then added drop-wise to former In solution, and it is kept stirring.Control speed of agitator, the concentration of chitosan oligosaccharide, the concentration of hyaluronic acid, chitosan oligosaccharide and hyaluronic acid The rate of addition of mass ratio and solution, to end of reaction, ultrasonic disperse is isolated and purified, and is dried to obtain chitosan oligosaccharide hyaluronic acid Composite nano particle.
The present invention have it is easy to operate, low in cost, preparation condition is mildly quick, and it is excellent not add emulsifier and dispersing agent etc. Point, raw material-chitosan oligosaccharide and hyaluronic acid used in the present invention have preferable biocompatibility, low toxicity, under physiological condition It is solvable, there is significant advantage as the application of drug delivery carrier in vivo.Significance of the invention is to prepare Obtained nanoparticle has well-regulated spherical shape, can be stabilized under neutrallty condition, be conducive to carry out drug under physiological condition Contain and discharge.In cell surface, there are the receptor CD44 of hyaluronic acid simultaneously, and it is multiple that this also gives chitosan oligosaccharide hyaluronic acid The intracorporal targeting of nanoparticle is closed, there is good research application prospect in biomaterial and cancer diagnosis and treatment.
Detailed description of the invention
Fig. 1: the schematic diagram (method one) of chitosan oligosaccharide hyaluronic acid composite nano particle
Fig. 2: the schematic diagram (method two) of chitosan oligosaccharide hyaluronic acid composite nano particle.
Specific embodiment
The present invention, as raw material, synthesizes target product by polymer agglomerates method using chitosan oligosaccharide.Specific embodiment are as follows:
Step 1: chitosan oligosaccharide and hyaluronic acid are dissolved in deionized water respectively, the concentration of chitosan oligosaccharide is 0.2%-1.2%, The concentration of hyaluronic acid is 0.2%-1.2%
Step 2:
Method one:
Hyaluronic acid solution is slowly dropped in chitosan oligosaccharide solution, the mass ratio of chitosan oligosaccharide and hyaluronic acid is 0.2-1: 1, when the dripping quantity of hyaluronic acid solution reaches 40%-60%, remaining hyaluronic acid is added drop-wise to by resulting reaction system is counter It in solution, completes to be added dropwise in 15-30 min, revolving speed is 200-500 revs/min, and the reaction time is 1-5 hours, and ultrasonic power is 100-150w, ultrasonic time are 5-10 minutes, and 20000 revs/min are centrifuged 20 minutes, discard supernatant liquid, are freeze-dried Obtain target product.
Method two:
Chitosan oligosaccharide solution is slowly dropped in hyaluronic acid solution, dripping quantity is the mass ratio of chitosan oligosaccharide and hyaluronic acid For 0.2-1:1, when the dripping quantity of chitosan oligosaccharide solution reaches 40%-60%, remaining shell is added drop-wise to by resulting reaction system is counter It in oligosaccharide solution, completes to be added dropwise in 15-30 min, revolving speed is 200-500 revs/min, and the reaction time is 1-5 hours, ultrasonic function Rate is 100-150w, and ultrasonic time is 5-10 minutes, and 20000 revs/min are centrifuged 20 minutes, discard supernatant liquid, is freeze-dried, Target product can be obtained.
The molecular weight of chitosan oligosaccharide in the present invention is 1000-5000Da, 90% or more deacetylation, the molecule of hyaluronic acid Amount is 10000-50000Da, the structural schematic diagram of products therefrom as shown in Figure 1, product is carried out partial size and Zeta potential is analyzed, The result shows that the uniform particle diameter of prepared nanoparticle, the coefficient of dispersion is in 0.093-0.195, and average grain diameter is in 120-200 Nm, nanometer system is more stable, Zeta potential -20mV -+30mV (table 1).The observation that transmission electron microscope is carried out to product, receives Rice particle is spherical in shape, and size is uniform, and be uniformly dispersed (Fig. 2).
The manufacturing method of the present invention is further provided for following specific embodiment.
Embodiment 1:
Taking 0.01 g molecular weight is that the chitosan oligosaccharide of 1500Da is dissolved in 5mL deionized water, under agitation, is slowly added dropwise (w/v) molecular weight of 2mL 0.4% is that it is transparent to be then added drop-wise to 3mL by the hyaluronic acid solution of 10000Da for resulting reaction system It in matter acid solution, drips off within 20 minutes, mixing speed is 300 revs/min, is reacted 2 hours, 100w ultrasound 5 minutes, 20000 revs/min Zhongli's heart 20 minutes, liquid is discarded supernatant, is freeze-dried up to chitosan oligosaccharide hyaluronic acid composite nano particle.
Embodiment 2:
Taking 0.02 g molecular weight is that the chitosan oligosaccharide of 2500Da is dissolved in 5mL deionized water, under agitation, is slowly added dropwise (w/v) molecular weight of 3mL 0.6% is that resulting reaction system is then added drop-wise to remaining by the hyaluronic acid solution of 20000Da In 2mL hyaluronic acid solution, dripping off within 30 minutes, mixing speed is 400 revs/min, it reacts 3 hours, 120w ultrasound 5 minutes, 20000 revs/min are centrifuged 20 minutes, discard supernatant liquid, are freeze-dried up to chitosan oligosaccharide hyaluronic acid composite nano particle.
Embodiment 3:
Taking 0.05g molecular weight is that the hyaluronic acid of 40000Da is dissolved in 5mL deionized water, under agitation, is slowly dripped Add 2mL 0.2%(w/v) molecular weight be 3500Da chitosan oligosaccharide solution it is few that resulting reaction system is then added drop-wise to 3mL shell It in sugar juice, drips off within 30 minutes, mixing speed is 200 revs/min, is reacted 4 hours, 120w ultrasound 10 minutes, 20000 revs/min Zhongli's heart 20 minutes, liquid is discarded supernatant, is freeze-dried up to chitosan oligosaccharide hyaluronic acid composite nano particle.
Embodiment 4:
Taking 0.06g molecular weight is that the hyaluronic acid of 50000Da is dissolved in 5mL deionized water, under agitation, is slowly dripped Add 3mL 0.3%(w/v) molecular weight be 5000Da chitosan oligosaccharide solution it is few that resulting reaction system is then added drop-wise to 2mL shell In sugar juice, being dripped off in 20 minutes, mixing speed is 500 revs/min, it reacts 5 hours, 150w ultrasound 10 minutes, 20000 turns/ Minute centrifugation 20 minutes, discards supernatant liquid, is freeze-dried up to chitosan oligosaccharide hyaluronic acid composite nano particle.
Subordinate list explanation
Table 1: average grain diameter, the coefficient of dispersion and the Zeta potential of chitosan oligosaccharide hyaluronic acid composite nano particle

Claims (1)

1. a kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle, it is characterized in that with polymer agglomerates method, it is specific to walk Suddenly are as follows: chitosan oligosaccharide, hyaluronic acid are dissolved in deionized water respectively, obtain chitosan oligosaccharide solution and hyaluronic acid solution, by shell widow Sugar juice is slowly dropped in hyaluronic acid solution under agitation, carries out polymer precipitation reaction, is dripped to chitosan oligosaccharide solution When dosage reaches 40-60%, stop being added dropwise, then resulting reaction system is reversely added drop-wise in chitosan oligosaccharide solution, and keeps stirring It mixes, the chitosan oligosaccharide hyaluronic acid composite nano particle of positive surface charge is prepared, or by hyaluronic acid solution in stirring bar It is slowly dropped under part in chitosan oligosaccharide solution, carries out polymer precipitation reaction and stop when hyaluronic acid dripping quantity reaches 40-60% It is only added dropwise, then resulting reaction system is reversely added drop-wise in hyaluronic acid solution, and is kept stirring, surface is prepared The molecular weight of the chitosan oligosaccharide hyaluronic acid composite nano particle of negative electrical charge, the chitosan oligosaccharide is 1000-5000Da, and deacetylation is big The concentration of chitosan oligosaccharide is 0.2%-1.2% in 90%, chitosan oligosaccharide solution, and the molecular weight of the hyaluronic acid is 10000- 50000Da, the concentration of hyaluronic acid is 0.2%-1.2% in hyaluronic acid solution, and the total mass ratio of chitosan oligosaccharide and hyaluronic acid is 0.2-1:1。
CN201410699380.2A 2014-11-28 2014-11-28 A kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle Active CN105694120B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410699380.2A CN105694120B (en) 2014-11-28 2014-11-28 A kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410699380.2A CN105694120B (en) 2014-11-28 2014-11-28 A kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle

Publications (2)

Publication Number Publication Date
CN105694120A CN105694120A (en) 2016-06-22
CN105694120B true CN105694120B (en) 2019-07-05

Family

ID=56294658

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410699380.2A Active CN105694120B (en) 2014-11-28 2014-11-28 A kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle

Country Status (1)

Country Link
CN (1) CN105694120B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108056101A (en) * 2016-11-08 2018-05-22 中国科学院大连化学物理研究所 A kind of chitosan oligosaccharide-alginic acid nano particle and its preparation and application
CN115212189A (en) * 2022-03-30 2022-10-21 江南大学 Nano-microsphere for improving oral bioavailability of chitosan oligosaccharide and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102605467A (en) * 2012-03-02 2012-07-25 北京化工大学 Method for preparing composite polyelectrolyte fiber membrane by utilizing freeze-drying way
CN102813937A (en) * 2012-06-12 2012-12-12 天津大学 Hydrophobic drug containing polyelectrolyte complex, its preparation method and application thereof
CN103656653A (en) * 2013-12-05 2014-03-26 天津大学 Polyelectrolyte compound based on hyaluronic acid drug-loading nano particles, preparation method and application thereof
CN103789874A (en) * 2014-01-23 2014-05-14 北京化工大学常州先进材料研究院 Method for preparing polyelectrolyte nano fibers in core-shell structures by parallel electric field inductive phase separation method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010003615A1 (en) * 2010-04-01 2011-10-06 Leibniz-Institut Für Polymerforschung Dresden E.V. Process for the preparation of a drug delivery system based on polyelectrolyte complexes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102605467A (en) * 2012-03-02 2012-07-25 北京化工大学 Method for preparing composite polyelectrolyte fiber membrane by utilizing freeze-drying way
CN102813937A (en) * 2012-06-12 2012-12-12 天津大学 Hydrophobic drug containing polyelectrolyte complex, its preparation method and application thereof
CN103656653A (en) * 2013-12-05 2014-03-26 天津大学 Polyelectrolyte compound based on hyaluronic acid drug-loading nano particles, preparation method and application thereof
CN103789874A (en) * 2014-01-23 2014-05-14 北京化工大学常州先进材料研究院 Method for preparing polyelectrolyte nano fibers in core-shell structures by parallel electric field inductive phase separation method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chitosan-Based Polyelectrolyte Complexes as Potential Nanoparticulate Carriers: Physicochemical and Biological Characterization;Thiruganesh Ramasamy等;《Pharm Res》;20131203;第31卷;第1302–1314页
Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells;Liu Yang等;《International Journal of Biological Macromolecules》;20141027;第72卷;第1391–1401页

Also Published As

Publication number Publication date
CN105694120A (en) 2016-06-22

Similar Documents

Publication Publication Date Title
Mohammed et al. Polysaccharides; classification, chemical properties, and future perspective applications in fields of pharmacology and biological medicine (a review of current applications and upcoming potentialities)
Zhang et al. Synthesis and antioxidant properties of Lycium barbarum polysaccharides capped selenium nanoparticles using tea extract
Zhang et al. Preparation of alginate-based biomaterials and their applications in biomedicine
Liu et al. Progress in rigid polysaccharide-based nanocomposites with therapeutic functions
CN102895258A (en) Pleurotus tuber-regium polysaccharide functionalized nanometer selenium hydrosol having anti-tumor activity and preparation method thereof
CN110279651A (en) A kind of hydrogel near infrared light realizing controlled-release immune substance system based on black phosphorus
Kesavan et al. Ulvan loaded graphene oxide nanoparticle fabricated with chitosan and d-mannose for targeted anticancer drug delivery
CN107375196A (en) A kind of natural polysaccharide composite aquogel carrier of phenolic group containing catechu and preparation method thereof
WO2020108495A1 (en) Beta-glucan solid dispersion and preparation method therefor
Gao et al. AuNRs@ MIL-101-based stimuli-responsive nanoplatform with supramolecular gates for image-guided chemo-photothermal therapy
CN108452317A (en) A kind of medicine-carried nano particles and preparation method thereof based on pectin/doxorubicin conjugates
CN102688195A (en) Preparation method for doxorubicin hydrochloride-entrapped chitosan carboxymethyl chitosan nanometer controlled-release particle with pH sensibility
CN105694120B (en) A kind of preparation method of chitosan oligosaccharide hyaluronic acid composite nano particle
CN108743540A (en) A kind of preparation method and applications of the multifunctional nano drug based on fibroin
CN104189917A (en) Preparation method of doxorubicin-containing graphene oxide medicine-carrying composite material
CN101856432A (en) Preparation method of chitosan nanoparticles encapsulated tea polyphenol
CN107260668B (en) Chondroitin sulfate A nano-selenium micelle particle and preparation method and application thereof
Chen et al. Specific β-glucans in chain conformations and their biological functions
Farokh et al. Assessment of synthesized chitosan/halloysite nanocarrier modified by carbon nanotube for pH-sensitive delivery of curcumin to cancerous media
Oves et al. Polysaccharide-based nanocomposites for gene delivery and tissue engineering
CN104288093B (en) Application of the nano drug transdermal preparation in tumour
Hemmati et al. In vitro evaluation of curcumin-loaded chitosan-coated hydroxyapatite nanocarriers as a potential system for effective treatment of cancer
Abad et al. Chitosan-Carbon nanotube Composite: an approach for controlled release of Quercetin, Modified with carboxymethyl Cellulose, for potential Anti-Cancer therapy
CN103242519A (en) Amphiphilic polymer as well as preparation method and application thereof
CN102516405B (en) Preparation method of chitosan oligosaccharide composite nanoparticles

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant